
Crescita Therapeutics Adjusts Valuation Amid Strong Sales Growth and Market Challenges
2025-11-11 16:26:05Crescita Therapeutics, Inc. has recently experienced a change in its evaluation, highlighting its financial metrics and market position. The company reported a 52.47% increase in net sales for the quarter ending June 2025 and achieved its highest operating cash flow, indicating effective cash management amidst a complex financial landscape.
Read MoreNo announcement available
Corporate Actions
No corporate action available






